Analyst Consensus ?
ConsensusHold37 ratings
Bullish1746.0%
Neutral1745.9%
Bearish38.1%
UDR, Inc. · UDR · FY2026 Q3 · Calendar Q4 2026
UDR Raises Outlook After Strong Q3 Operating Results
UDR’s operating momentum and raised outlook are constructive, while deployment of Apollo proceeds, Sunbelt performance and the fee impact remain important tests of execution.
Reported After market closeNYSEReal Estate
$11.54B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.67
Consensus $0.15
EPS surprise
+340.8%
Reported versus consensus
Reported revenue
$428.1M
Consensus $427.8M
Revenue surprise
+0.1%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+0.1%
Event window
SPY move
+0.3%
Same window
Abnormal move
-0.1%
Stock minus SPY
Volume
1.2×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
UDRSPY benchmark
Ask FN2 about UDR FY2026 Q3
Transcript, numbers and history already loaded
Why did UDR rise 0.1% after beating EPS estimates in FY2026 Q3?What changed in UDR's guidance and outlook in FY2026 Q3?Give me the bull and bear case for UDR after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management reported Q3 results above expectations and raised its full-year same-store growth and FFOA outlook. The Apollo joint venture adds capital-allocation flexibility; management also highlighted strong coastal performance and improving Sunbelt momentum.
Guidance delta
Raised full-year same-store growth and FFOA guidance, following a second increase this year, according to the supplied analysis. 2027 guidance is expected in February after Apollo proceeds are deployed.
Key takeaways
- Q3 results topped the high end of guidance, prompting another full-year outlook increase.
- Management described data-led leasing and resident retention as supports for operating performance.
- The Apollo joint venture provides capital and asset-substitution flexibility, but proceeds deployment remains an execution issue.
Management priorities
- Deploy Apollo proceeds with attention to acquisitions, debt reduction and share repurchases.
- Use Orion analytics to guide leasing, rent-growth forecasts and asset decisions.
- Pursue selective acquisitions and maintain disciplined capital allocation.
Follow UDR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$35.93Current
$35Low
$44.09Average
$64High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 19, 2026 |
| UBS | Buy | Buy | Maintain | Oct 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 14, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 13, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 21, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Sep 17, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Sep 8, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 12, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Aug 4, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Jul 21, 2026 |
| Truist Securities | Hold | Buy | Downgrade | Jul 8, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 6, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 17, 2026 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Feb 13, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Aug 5, 2024 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 15, 2024 |
| Baird | Outperform | Outperform | Maintain | Mar 12, 2024 |
| Keybanc | Overweight | Overweight | Maintain | Dec 13, 2023 |
| B of A Securities | Neutral | Buy | Downgrade | Oct 31, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | May 15, 2023 |
| Jefferies | Buy | Buy | Maintain | Oct 19, 2022 |
| Capital One | Overweight | Equal Weight | Upgrade | Nov 16, 2021 |
| BTIG | Buy | Neutral | Upgrade | Sep 13, 2021 |
| Stifel | Buy | Buy | Maintain | May 8, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Apr 2, 2020 |
| Capital One Financial | Overweight | Equal Weight | Upgrade | Sep 16, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 25, 2018 |
| Bank of America | Buy | Buy | Maintain | Jun 8, 2018 |
| BTIG Research | Neutral | Buy | Downgrade | Jun 30, 2017 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jan 19, 2016 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jan 12, 2016 |
| Miller Tabak | Sell | Hold | Downgrade | Nov 9, 2015 |
| Credit Suisse | Neutral | Underperform | Upgrade | Oct 27, 2015 |
| ISI Group | Buy | Neutral | Upgrade | Nov 18, 2013 |
| Compass Point | Neutral | Neutral | Maintain | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $35.93. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Ami Probandt | $39 | $33.91 | +8.5% | Oct 14, 2026 |
| Piper Sandler | Alexander Goldfarb | $36 | $34.12 | +0.2% | Oct 12, 2026 |
| Evercore ISI | Analyst unavailable | $41 | $33.78 | +14.1% | Sep 21, 2026 |
| UBS | Ami Probandt | $41 | $35.37 | +14.1% | Sep 15, 2026 |
| Mizuho Securities | Analyst unavailable | $39 | $36.38 | +8.5% | Sep 8, 2026 |
| Wells Fargo | Analyst unavailable | $43 | $36.95 | +19.7% | Sep 1, 2026 |
| Deutsche Bank | Peter Abramowitz | $44 | $37.92 | +22.5% | Aug 14, 2026 |
| Morgan Stanley | Analyst unavailable | $42 | $37.3 | +16.9% | Aug 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $41 | $38.7 | +14.1% | Aug 3, 2026 |
| Goldman Sachs | Julien Blouin | $38 | $38.3 | +5.8% | Jul 30, 2026 |
| Wells Fargo | Analyst unavailable | $44 | $39.57 | +22.5% | Jul 22, 2026 |
| Deutsche Bank | Peter Abramowitz | $45 | $39.74 | +25.2% | Jul 20, 2026 |
| Barclays | Richard Hightower | $46 | $40.18 | +28.0% | Jul 14, 2026 |
| Scotiabank | Nicholas Yulico | $41 | $39.79 | +14.1% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $41 | $39.37 | +14.1% | Jun 10, 2026 |
| Scotiabank | Analyst unavailable | $38 | $37.52 | +5.8% | May 14, 2026 |
| Barclays | Analyst unavailable | $41 | $36.91 | +14.1% | May 11, 2026 |
| Cantor Fitzgerald | Richard Anderson | $39 | $36.39 | +8.5% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $35 | $34.25 | -2.6% | Apr 17, 2026 |
| Piper Sandler | Analyst unavailable | $41 | $38.09 | +14.1% | Feb 17, 2026 |
| Goldman Sachs | Analyst unavailable | $39 | $38.17 | +8.5% | Feb 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $42 | $39.38 | +16.9% | Feb 11, 2026 |
| RBC Capital | Brad Heffern | $39 | $39.38 | +8.5% | Feb 10, 2026 |
| Goldman Sachs | Julien Blouin | $37.5 | $37.64 | +4.4% | Jan 20, 2026 |
| UBS | Michael Goldsmith | $42 | $36.82 | +16.9% | Jan 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $37 | $36.55 | +3.0% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $41 | $36.42 | +14.1% | Dec 1, 2025 |
| Barclays | Analyst unavailable | $44 | $35.63 | +22.5% | Nov 25, 2025 |
| Mizuho Securities | Analyst unavailable | $38 | $35.59 | +5.8% | Nov 24, 2025 |
| Goldman Sachs | Analyst unavailable | $33 | $33.79 | -8.2% | Nov 4, 2025 |
| Piper Sandler | Analyst unavailable | $39 | $33.69 | +8.5% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $44 | $35.71 | +22.5% | Oct 13, 2025 |
| Wells Fargo | Analyst unavailable | $41 | $35.71 | +14.1% | Oct 13, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $40 | $37.26 | +11.3% | Oct 1, 2025 |
| Barclays | Analyst unavailable | $45 | $36.94 | +25.2% | Sep 30, 2025 |
| Evercore ISI | Steve Sakwa | $45 | $38.37 | +25.2% | Sep 15, 2025 |
| BMO Capital | Analyst unavailable | $44 | $38.39 | +22.5% | Sep 4, 2025 |
| Truist Financial | Michael Lewis | $43 | $38.95 | +19.7% | Aug 26, 2025 |
| Morgan Stanley | Adam Kramer | $44.5 | $37.83 | +23.9% | Aug 13, 2025 |
| Evercore ISI | Steve Sakwa | $46 | $40.8 | +28.0% | Jul 7, 2025 |
| RBC Capital | Brad Heffern | $46 | $45.34 | +28.0% | Oct 1, 2024 |
| Evercore ISI | Steve Sakwa | $43 | $44.05 | +19.7% | Sep 9, 2024 |
| Goldman Sachs | Julien Blouin | $42 | $44.92 | +16.9% | Sep 4, 2024 |
| Evercore ISI | Steve Sakwa | $42 | $43.64 | +16.9% | Aug 28, 2024 |
| Piper Sandler | Alexander Goldfarb | $46 | $43.3 | +28.0% | Aug 26, 2024 |
| BMO Capital | Juan Sanabria | $45 | $40.56 | +25.2% | Jul 15, 2024 |
| Robert W. Baird | Amanda Sweitzer | $42 | $39.02 | +16.9% | May 24, 2024 |
| Scotiabank | Nicholas Yulico | $42 | $39.28 | +16.9% | May 14, 2024 |
| Scotiabank | Sector Perform | $39 | $38.08 | +8.5% | May 1, 2024 |
| UBS | Michael Goldsmith | $44 | $37.89 | +22.5% | Apr 25, 2024 |
| Piper Sandler | Alexander Goldfarb | $40 | $37.87 | +11.3% | Apr 10, 2024 |
| Truist Financial | Michael Lewis | $42 | $37.63 | +16.9% | Apr 9, 2024 |
| Wells Fargo | James Feldman | $39 | $37.28 | +8.5% | Mar 4, 2024 |
| UBS | Michael Goldsmith | $43 | $38.04 | +19.7% | Sep 19, 2023 |
| Scotiabank | Nicholas Yulico | $45 | $40.19 | +25.2% | Aug 30, 2023 |
| Scotiabank | Nicholas Yulico | $58 | $46.48 | +61.4% | May 19, 2022 |
| Piper Sandler | Alexander Goldfarb | $57 | $51.83 | +58.6% | May 4, 2022 |
| Truist Financial | Michael R Lewis | $59 | $56.75 | +64.2% | Dec 6, 2021 |
| Wells Fargo | Tammi Fique | $61 | $54.93 | +69.8% | Nov 22, 2021 |
| Capital One Financial | Neil Malkin | $64 | $55.43 | +78.1% | Nov 16, 2021 |
| Morgan Stanley | Richard Hill | $59.5 | $54.19 | +65.6% | Nov 8, 2021 |
| Goldman Sachs | Chandni Luthra | $60 | $52.95 | +67.0% | Sep 23, 2021 |
| Piper Sandler | Alexander Goldfarb | $58 | $54.23 | +61.4% | Sep 1, 2021 |
Track every rating change on UDR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationUDR, Inc. (NYSE: UDR), a distinguished S&P 500 company, stands as a premier multifamily real estate investment trust. The company boasts a proven history of generating exceptional and reliable returns for its investors, achieving this through the astute management, acquisition, disposition, development, and redevelopment of appealing real estate properties situated in key U.S. markets. As of September 30, 2020, UDR's extensive portfolio included ownership or partial ownership in 51,649 apartment homes, with an additional 1,031 units currently under development. With over 48 years in operation, UDR has consistently delivered long-term value to its shareholders, provided superior service to its residents, and fostered a high-quality experience for its associates.
Historical context
All UDR earningsReal Estate peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DOC Healthpeak Properties, Inc. | FY2026 Q3 · Calendar Q4 2026 | -68.5% | +0.4% | Healthpeak lifts FY2026 outlook again as leasing and operations strengthen |
| O Realty Income Corporation | FY2026 Q3 · Calendar Q4 2026 | +5.7% | +1.1% | Realty Income raises 2026 AFFO outlook as Europe and credit broaden investment mix |
| SBAC SBA Communications Corporation | FY2026 Q3 · Calendar Q4 2026 | +4.8% | -1.2% | SBA Communications Raises AFFO Guidance as Edge Computing Develops |
Latest beats and misses
Who reports nextBeat on EPS
- FANGFY2026 Q3 · November 2, 2026+2.4% EPS-3.7% move
- RRXFY2026 Q3 · November 3, 2026+41.1% EPS+11.8% move
- VNOMFY2026 Q3 · November 2, 2026+3.9% EPS-2.6% move
- EQH-PAFY2026 Q3 · November 2, 2026+14.5% EPS— move
- WMBFY2026 Q3 · November 2, 2026+0.2% EPS+3.5% move
- TSEMFY2026 Q3 · November 2, 2026+7.5% EPS-6.7% move
Get the UDR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-03T20:19:12.419011+00:00
- FN2 earnings calendar · 2026-11-03T01:23:13.143323+00:00
- Polygon adjusted daily market bars · 2026-11-03T20:50:43.963087+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T20:50:43.960437+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.